Eagle Pharmaceuticals Inc. Daily Stock Analysis

Daily Stock Analysis, EGRX, Eagle Pharmaceuticals Inc, priceseries

Eagle Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
43.10
Close
47.75
High
48.32
Low
43.10
Previous Close
45.10
Daily Price Gain
2.65
YTD High
52.98
YTD High Date
Jan 5, 2022
YTD Low
43.10
YTD Low Date
Mar 7, 2022
YTD Price Change
-4.65
YTD Gain
-8.87%
52 Week High
58.25
52 Week High Date
Oct 4, 2021
52 Week Low
36.48
52 Week Low Date
Jun 2, 2021
52 Week Price Change
3.96
52 Week Gain
9.04%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 14. 2017
73.04
Jun 29. 2017
79.17
11 Trading Days
8.40%
Link
LONG
Jul 5. 2018
76.53
Jul 24. 2018
81.56
13 Trading Days
6.57%
Link
LONG
Feb 14. 2019
40.53
Mar 7. 2019
46.89
14 Trading Days
15.69%
Link
LONG
May 3. 2019
51.12
May 15. 2019
55.12
8 Trading Days
7.82%
Link
LONG
Oct 9. 2019
59.32
Oct 31. 2019
62.83
16 Trading Days
5.92%
Link
LONG
Oct 5. 2020
42.87
Oct 26. 2020
46.12
15 Trading Days
7.58%
Link
LONG
Jun 9. 2021
38.87
Jun 23. 2021
41.24
10 Trading Days
6.09%
Link
LONG
Jul 8. 2021
44.11
Jul 26. 2021
47.56
12 Trading Days
7.81%
Link
LONG
Sep 22. 2021
51.45
Oct 14. 2021
55.03
16 Trading Days
6.95%
Link
Company Information
Stock Symbol
EGRX
Exchange
NasdaqGM
Company URL
http://www.eagleus.com
Company Phone
201-326-5300
CEO
Scott L. Tarriff
Headquarters
New Jersey
Business Address
50 TICE BOULEVARD, SUITE 315, WOODCLIFF LAKE, NJ 07677
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0000827871
About

Eagle Pharmaceuticals, Inc. is a pharmaceutical company engages in the provision of injectable products. Its activities include development and commercialization of pharmaceutical products for the treatment of areas such as critical care, orphan diseases, and oncology. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.

Description

Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban for heparin-induced thrombocytopenia; Ryanodex for malignant hyperthermia; non-alcohol docetaxel injection, a chemotherapeutic agent for breast, non-small cell lung, prostate, head, and neck cancers/gastric adenocarcinoma; and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates includes include EP-4104, a dantrolene sodium for exertional heat stroke; EGL-4104-C-1702, dantrolene sodium for drug induced hyperthermia; EP-5101 (pemetrexed) for lung cancer and mesothelioma; and EGL-5385-C-1701 (fulvestrant) for breast cancer. Eagle Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Woodcliff Lake, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading